# TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.

> **NCT06117722** · — · UNKNOWN · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 210 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **OTHER:** Eplerenone torasemide in chronic heart failure

## Key facts

- **NCT ID:** NCT06117722
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-06
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2024-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06117722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06117722, "TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06117722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*